ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
about
Major clinical research advances in gynecologic cancer in 2015Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.A Review of mTOR Pathway Inhibitors in Gynecologic CancerThe role of pathology in the management of patients with endometrial carcinoma.Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye.Endometrial cancer: Not your grandmother's cancer.Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why gePredicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.Surgical management of non-invasive uterine clear cell carcinoma.Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial.miR-145 targets the SOX11 3'UTR to suppress endometrial cancer growth.Fertility-Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot Study.Advances in endometrial cancer protein biomarkers for use in the clinic.Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye.Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer.Evaluation of deep myometrial invasion in endometrial cancer patients: is dual-energy CT an option?SEOM clinical guidelines for endometrial cancer (2017).Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue.Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.Appendix 5: Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org/Guidelines/Gynaecological-Cancers).[Grading of gynecological tumors : Current aspects].Computational development of a molecular-based approach to improve risk stratification of endometrial cancer patients.Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer.Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers.Expression of miR-106 in endometrial carcinoma RL95-2 cells and effect on proliferation and invasion of cancer cellsDNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial CancerClinical utility of chromatin analysisA study of the application of TAP combined with transvaginal ultrasound in the diagnosis of early-stage endometrial cancerClinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases
P2860
Q28077183-A2718222-8814-4284-84D1-3FAC88EFF5A7Q37512356-D8E8BF44-999E-4F30-931E-28E35C078C9FQ37668889-63E0C151-269F-43A3-85CD-4C4459280F59Q38686652-02399A31-EC7E-4F16-A40E-5969E064CF23Q38798648-21ECF312-ED55-47A1-9DF9-147143836A78Q38852405-121DBEF1-96D9-4C4C-8873-078EF305B936Q39036939-5CA9B531-6520-419E-8B0E-633F974059A1Q39196985-77D0DF31-6054-4C7E-AEB7-1CD1C07BF3AEQ39204658-A830BF03-ADF5-4DEC-A025-51B26692A9DAQ39290822-14300513-7D1C-4521-A58A-870E7665AF1BQ42345755-C723D708-1E6D-46AD-89D5-4244AA29A7FDQ47140613-5F32F1F7-B888-4986-8402-98867DA090E1Q47154666-55CB0CAE-14B1-40D5-9917-9389D1045D3CQ47297066-86C3C731-D69C-477C-9BC6-72BE3D709D4BQ47355920-A61F61FA-A25A-4C81-9D30-11C68F0480A2Q47368546-61670742-CEDF-42CF-8851-6E7EE56733E9Q47385390-9BB48E78-DA61-4A7D-8D2F-5B8F6E968C36Q47762804-08422D76-11F8-4DCF-9E4C-20AE9778C334Q47880111-8FB33F68-6864-49FB-B31B-C78110560FB8Q48120731-35094116-860B-4BC6-9A65-7FF9132CA178Q48204704-77A17E37-40C5-49D1-9A61-56523EEA6DBDQ49367303-C5097F78-3757-4488-BB60-0C13618698B6Q50205162-6035BC28-8479-4F7B-A731-E83369D2CB06Q52861155-815B5C4D-9A88-4B5D-9B37-A96AAF9057CFQ54940052-A67F2388-061E-4F77-88D6-E1C231DE72FBQ55278788-DD28D8DE-C991-4B28-8BB3-67452A75EA5CQ55510327-E14C2406-097A-4CE4-8C42-03A85D3E38F5Q57173328-16FB37C4-0790-4D08-A546-9F98C4BA442EQ58726243-F20660E9-0A3C-491B-821B-B9E4516108ADQ58727476-19093DEF-3709-4749-97A5-87BAACA42D05Q58804285-B3CD6D32-0130-4DF6-BCF1-FB2D6927474FQ59135515-EA9D998D-3796-4B2C-8D4A-C8C472F3B65C
P2860
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
description
im Dezember 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2015
@uk
name
ESMO-ESGO-ESTRO Consensus Conf ...... nosis, treatment and follow-up
@en
ESMO-ESGO-ESTRO Consensus Conf ...... nosis, treatment and follow-up
@nl
type
label
ESMO-ESGO-ESTRO Consensus Conf ...... nosis, treatment and follow-up
@en
ESMO-ESGO-ESTRO Consensus Conf ...... nosis, treatment and follow-up
@nl
prefLabel
ESMO-ESGO-ESTRO Consensus Conf ...... nosis, treatment and follow-up
@en
ESMO-ESGO-ESTRO Consensus Conf ...... nosis, treatment and follow-up
@nl
P2093
P2860
P356
P1433
P1476
ESMO-ESGO-ESTRO Consensus Conf ...... nosis, treatment and follow-up
@en
P2093
A. González-Martín
D. Querleu
J. Ledermann
M.R. Mirza
N. Colombo
P2860
P356
10.1093/ANNONC/MDV484
P577
2015-12-02T00:00:00Z